Prognostic value of [18F]-FDG PET/CT in patients with meta-static breast cancer treated with cyclin-dependent inhibitors

Prognostic value of [18F]-FDG PET/CT in patients with meta-static breast cancer treated with cyclin-dependent inhibitors

ObjectiveThe addition of cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) to endocrine therapy impressively improved the outcome of patients with hormone receptor-positive metastatic breast cancer. Despite their great efficacy, not all patients respond to treatment and many of them develop acquired...

Full description

Bibliographic Details
Main Authors: Alessio Annovazzi, Sandra Rea, Daria Maccora, Laura Pizzuti, Gianluigi Ferretti, Patrizia Vici, Federico Cappuzzo, Rosa Sciuto
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Oncology
Subjects:
PET-CT scan
fluorodeoxyglucose F18
breast cancer
cyclin-dependent kinase 4
progression-free and overall survival
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1193174/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1193174/full

Similar Items